X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (48) 48
cancer (37) 37
immunotherapy (37) 37
oncology (32) 32
humans (30) 30
cancer immunity (29) 29
animals (20) 20
immune system (20) 20
tumors (19) 19
immune response (17) 17
immunology (17) 17
dendritic cells (16) 16
t cells (16) 16
cancer-immunity (15) 15
research (14) 14
care and treatment (13) 13
antigens (12) 12
lymphocytes (12) 12
lymphocytes t (12) 12
melanoma (12) 12
tumor microenvironment (12) 12
cancer-immunity cycle (11) 11
chemotherapy (11) 11
gene expression (11) 11
mice (11) 11
neoplasms - immunology (11) 11
cancer therapies (10) 10
cell biology (10) 10
cytotoxicity (10) 10
health aspects (10) 10
immune checkpoint (10) 10
immunity (10) 10
apoptosis (9) 9
proteins (9) 9
t-cells (9) 9
analysis (8) 8
biochemistry & molecular biology (8) 8
cd8 antigen (8) 8
metastasis (8) 8
pd-1 blockade (8) 8
review (8) 8
usage (8) 8
cell death (7) 7
expression (7) 7
lung cancer (7) 7
lung-cancer (7) 7
macrophages (7) 7
medical prognosis (7) 7
neoplasms - therapy (7) 7
pd-1 (7) 7
pd-l1 (7) 7
regulatory t-cells (7) 7
antibodies, monoclonal - therapeutic use (6) 6
antitumor immunity (6) 6
article (6) 6
biology (6) 6
biomarkers (6) 6
breast cancer (6) 6
cancer immunity cycle (6) 6
clinical trials (6) 6
female (6) 6
genetic aspects (6) 6
inflammation (6) 6
metastases (6) 6
neoplasms - genetics (6) 6
pancreatic cancer (6) 6
tumor microenvironment - immunology (6) 6
anti-cancer immunity (5) 5
antigen presentation (5) 5
binding (5) 5
breast-cancer (5) 5
cancer immunotherapy (5) 5
cd4 antigen (5) 5
cells (5) 5
checkpoint blockade (5) 5
gene expression regulation, neoplastic (5) 5
immunohistochemistry (5) 5
ligands (5) 5
mutation (5) 5
neoplasms. tumors. oncology. including cancer and carcinogens (5) 5
patients (5) 5
solid tumors (5) 5
t-lymphocytes - immunology (5) 5
therapy (5) 5
vaccines (5) 5
activation (4) 4
aged (4) 4
bioscience (4) 4
breast cancer immunity (4) 4
calcium (4) 4
carcinogenesis (4) 4
cell (4) 4
cycle (4) 4
deoxyribonucleic acid--dna (4) 4
drug therapy (4) 4
flow cytometry (4) 4
genetic engineering (4) 4
genetics & heredity (4) 4
glioblastoma (4) 4
homeostasis (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Cellular Physiology, ISSN 0021-9541, 09/2018, Volume 233, Issue 9, pp. 6518 - 6523
Journal Article
Frontiers in Immunology, ISSN 1664-3224, 2019, Volume 10, p. 774
Reactivation of cytotoxic CD8(+) T-cell responses has set a new direction for cancer immunotherapy. Neutralizing antibodies targeting immune checkpoint... 
C3a | C1q | Cancer immunity | Immunotherapy | PD-L1 | Complement system | PD-1 | C5a | complement system | ACTIVATION PRODUCT C4D | FACTOR-H | cancer immunity | IMMUNOLOGY | ANAPHYLATOXIN C5A | C5A RECEPTOR | T-CELL RESPONSES | POOR-PROGNOSIS | immunotherapy | APOPTOTIC CELLS | THERAPEUTIC CONTROL | ANTITUMOR IMMUNITY | INTRACELLULAR COMPLEMENT
Journal Article
Frontiers in immunology, ISSN 1664-3224, 2018, Volume 9, p. 3185
Depletion of CD4(+) cells using an anti-CD4 monoclonal antibody (anti-CD4 mAb) induces the expansion of tumor-reactive CD8(+) T cells and strong antitumor... 
immune checkpoint inhibitor | Cancer-Immunity Cycle | anti-CD4 mAb | Inter-Organ Clone Tracking | TCR repertoire | TUMOR | IMMUNOLOGY | NIVOLUMAB | Usage | Antigen receptors, T cell | Receptors | Immune response | Oncology, Experimental | High-throughput screening (Biochemical assaying) | Research | T cells | Cancer
Journal Article
Pancreas, ISSN 0885-3177, 02/2018, Volume 47, Issue 2, pp. 142 - 157
Journal Article
Seminars in Cancer Biology, ISSN 1044-579X, 2017, Volume 45, pp. 23 - 35
Abstract Cell therapy is an advanced form of cancer immunotherapy that has had remarkable clinical progress in the past decade in the search for cure of... 
Hematology, Oncology and Palliative Medicine | Dendritic cell vaccines | Gene therapy | Cancer immunotherapy | CAR T-cells | Cancer-immunity cycle | HUMAN DENDRITIC CELLS | SECRETE IL-12 | ANTITUMOR RESPONSES | SERIOUS ADVERSE EVENT | CHIMERIC ANTIGEN RECEPTORS | ADOPTIVE TRANSFER | ONCOLOGY | ON-TARGET | PHASE-I | LYMPHOCYTE INFILTRATION | TUMOR MICROENVIRONMENT | Neoplasms - metabolism | Genetic Therapy | Immunomodulation - drug effects | Immunotherapy - methods | Dendritic Cells - immunology | Humans | Immunomodulation - genetics | Antineoplastic Agents - therapeutic use | Cancer Vaccines - genetics | Immunity - drug effects | Neoplasms - therapy | Tumor Microenvironment - genetics | Neoplasms - genetics | T-Lymphocytes - metabolism | Drug Design | Antineoplastic Agents - pharmacology | Dendritic Cells - metabolism | Receptors, Antigen, T-Cell - metabolism | Antigens, Neoplasm - immunology | Cell- and Tissue-Based Therapy | Immunotherapy - adverse effects | Tumor Microenvironment - immunology | Cancer Vaccines - immunology | Animals | Genetic Engineering | Neoplasms - immunology | T-Lymphocytes - immunology | Receptors, Antigen, T-Cell - genetics | Immunity - genetics | Antigens | Dendritic cells | Leukemia | Immunotherapy | Lymphomas | Vaccines | Drug therapy | T cells | Basic Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Cell and Molecular Biology | Klinisk medicin | Clinical Medicine | Medicinska och farmaceutiska grundvetenskaper | Cancer and Oncology | Cell- och molekylärbiologi | Cancer och onkologi
Journal Article
JOURNAL OF THORACIC ONCOLOGY, ISSN 1556-0864, 05/2017, Volume 12, Issue 5, pp. 791 - 803
Introduction: The interaction of immune cells and cancer cells shapes the immunosuppressive tumor microenvironment. For successful cancer immunotherapy,... 
CELLS | NETMHCPAN | LANDSCAPE | Lung cancer | Transcriptome | SENSITIVITY | Immunogram | DOCETAXEL | Cancer-immunity cycle | ONCOLOGY | RESPIRATORY SYSTEM | NEOANTIGENS | MUTATIONS | BLOCKADE | NIVOLUMAB | BINDING | Neoantigen
Journal Article
Journal Article
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 01/2019, Volume 127, pp. 161 - 174
Journal Article
Oncotarget, ISSN 1949-2553, 04/2018, Volume 9, Issue 32, pp. 22802 - 22816
Immunotherapeutics have revolutionized the management of solid malignancies over the last few years. Nevertheless, despite relative successes of checkpoint... 
Clinical trials | Checkpoint inhibitors | Immunotherapy | Cancer-immunity cycle | Glioblastoma
Journal Article
Genome Biology, ISSN 1474-7596, 08/2016, Volume 17, Issue 1, p. 174
Journal Article